PHARMA 2100 ApS: Financial statements 2015
CVR: 26382785
Source: annual report 2015, Danish Business Authority
01/07/2014 – 30/06/2015
PHARMA 2100 ApS (CVR 26382785) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -2,166 and a net result of DKK -2,166 compared with DKK -5,348 the year before. Equity in the 2015 report amounted to DKK 49,826. The solvency ratio was 100%.
- Gross Profit
- DKK -2,166
- Profit/Loss
- DKK -2,166
- Equity
- DKK 49,826
- Total Assets
- DKK 49,826
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | -2 t. | -2 t. | 50 t. | - |
| 2014 | 0 | -5 t. | -5 t. | 52 t. | - |
| 2013 | 0 | -250 | -25 t. | 57 t. | - |
| 2012 | 0 | 0 | -50 t. | 83 t. | - |
Official annual report
How creditworthy is PHARMA 2100 ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout PHARMA 2100 ApS
PHARMA 2100 ApS was a Danish company of the type Anpartsselskab based in Roskilde, founded in 2002. The company has been dissolved on 23 October 2018. The company was registered under the industry Industriel design og produktdesign. The company has 1 employee (2009). In 2017, the company reported a gross profit of DKK -20,455 and a net result of DKK -20,455 compared with DKK 0 the year before. Equity in the 2017 report amounted to DKK 29,371.